Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX gene exp...

Full description

Bibliographic Details
Main Authors:	Ming-Fu eChiang, Pei-Yi eChou, Wan-Jen eWang, Chun-I eSze, Nan-Shan eChang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-03-01
Series:	Frontiers in Oncology
Subjects:	p53 tumor suppressor Glioblastoma Multiforme WWOX temozolomide resistance
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00043/full

Similar Items

A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism
by: Pei-Yi Chou, et al.
Published: (2019-07-01)

WWOX Controls Cell Survival, Immune Response and Disease Progression by pY33 to pS14 Transition to Alternate Signaling Partners
by: Tsung-Yun Liu, et al.
Published: (2022-07-01)

WWOX and Its Binding Proteins in Neurodegeneration
by: Che-Yu Hsu, et al.
Published: (2021-07-01)

Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration
by: Yu-An Chen, et al.
Published: (2024-03-01)

WWOX Phosphorylation, Signaling, and Role in Neurodegeneration
by: Chan-Chuan Liu, et al.
Published: (2018-08-01)

WWOX Possesses <i>N</i>-Terminal Cell Surface-Exposed Epitopes WWOX<sub>7-21</sub> and WWOX<sub>7-11</sub> for Signaling Cancer Growth Suppression and Prevention In Vivo
by: Wan-Jen Wang, et al.
Published: (2019-11-01)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
by: Monique eDontenwill, et al.
Published: (2012-10-01)

WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions
by: Karolina Pospiech, et al.
Published: (2018-08-01)

Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
by: Żaneta Kałuzińska-Kołat, et al.
Published: (2023-09-01)

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
by: Jiao Meng, et al.
Published: (2024-03-01)

Antineoplastic Nature of <i>WWOX</i> in Glioblastoma Is Mainly a Consequence of Reduced Cell Viability and Invasion
by: Żaneta Kałuzińska-Kołat, et al.
Published: (2023-03-01)

Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
by: Mariana Ataydes Leite Seabra, et al.
Published: (2018-02-01)

Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review
by: Fateen Ata, et al.
Published: (2021-03-01)

Delta-radiomics Entropy Based on Tumor Heterogeneity Concept – Response Predictor to Irradiation for Unresectable/recurrent Glioblastoma
by: Camil Ciprian MIRESTEAN, et al.
Published: (2022-12-01)

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX
by: Florian Bonin, et al.
Published: (2018-10-01)

Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide
by: Lu-Ting Kuo, et al.
Published: (2017-01-01)

MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells
by: Athena F. Phoa, et al.
Published: (2020-03-01)

Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)

Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management
by: Brandon Edelbach, et al.
Published: (2024-03-01)

A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines
by: Barbara Brandt, et al.
Published: (2023-04-01)

Hypofractionated Radiation Therapy with Temozolomide for Patients with Glioblastoma Multiforme Recursive Partitioning Analyzes Class V and VI
by: Fuzuli Tuğrul, et al.
Published: (2019-09-01)

Recurrent Glioblastoma: Where we stand
by: Sanjoy Roy, et al.
Published: (2015-01-01)

De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells
by: Megan Pitz, et al.
Published: (2022-09-01)

Zfra Inhibits the TRAPPC6AΔ-Initiated Pathway of Neurodegeneration
by: Yu-Hao Lin, et al.
Published: (2022-11-01)

Substituted Caffeic and Ferulic Acid Phenethyl Esters: Synthesis, Leukotrienes Biosynthesis Inhibition, and Cytotoxic Activity
by: Pier Morin, et al.
Published: (2017-07-01)

<i>PLEK2</i>, <i>RRM2</i>, <i>GCSH</i>: A Novel <i>WWOX</i>-Dependent Biomarker Triad of Glioblastoma at the Crossroads of Cytoskeleton Reorganization and Metabolism Alterations
by: Żaneta Kałuzińska, et al.
Published: (2021-06-01)

Novel homozygous mutation in the WWOX gene causes seizures and global developmental delay: Report and review
by: Ehaideb Salleh N., et al.
Published: (2018-12-01)

Editorial: WW Domain Proteins in Signaling, Cancer Growth, Neural Diseases, and Metabolic Disorders
by: Nan-Shan Chang, et al.
Published: (2019-08-01)

Molecular Functions of WWOX Potentially Involved in Cancer Development
by: Karim Taouis, et al.
Published: (2021-04-01)

Evaluation of Hydro-Alcoholic Extract of Trifolium Pratens L. for Its Anti-Cancer Potential on U87MG Cell Line
by: Mozafar Khazaei, et al.
Published: (2018-06-01)

Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States
by: Jigang Chen, et al.
Published: (2021-09-01)

WWOX Modulates ROS-Dependent Senescence in Bladder Cancer
by: Ching-Wen Liu, et al.
Published: (2022-10-01)

Editorial: The role of STAT3 signaling pathway in tumor progression
by: Nan-Shan Chang, et al.
Published: (2023-02-01)

Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo
by: Alexandra Y. Tsidulko, et al.
Published: (2018-10-01)

The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
by: Łukasz A. Poniatowski, et al.
Published: (2024-01-01)

Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma
by: Susanne Flor, et al.
Published: (2021-12-01)

Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis
by: Sheng-Po Chiu, et al.
Published: (2019-05-01)

Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
by: Ming Chen, et al.
Published: (2023-06-01)

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation
by: Luca Napoleoni, et al.
Published: (2019-01-01)

Thymoquinone synergistically potentiates temozolomide cytotoxicity through the inhibition of autophagy in U87MG cell line
by: Mona Pazhouhi, et al.
Published: (2016-08-01)